Pathodynamics of Nitric Oxide Production Within Implanted Glioma Studied With an In Vivo Microdialysis Technique and Immunohistochemistry.

  • Oyoshi Tatsuki
    Department of Neurosurgery, Faculty of Medicine, Kagoshima University
  • Nomoto Masahiro
    Department of Clinical Pharmacology and Therapeutics, Ehime University School of Medicine
  • Hirano Hirofumi
    Department of Neurosurgery, Faculty of Medicine, Kagoshima University
  • Kuratsu Jun-ichi
    Department of Neurosurgery, Faculty of Medicine, Kagoshima University

この論文をさがす

抄録

Nitric oxide (NO) is thought to be a mediator in many of the processes of malignant brain tumor progression. We examined NO production in the brain of normal conscious, freely moving rats with or without implanted C6 glioma. Both nitrite (NO2) and nitrate (NO3) in the dialysates of the two groups were measured using an in vivo microdialysis technique. The mean concentration of NO2 in the glioma group was two-times higher than that in the control group (P<0.01). Concentrations of both NO2 and NO3 in the glioma and control groups decreased following intraperitoneal injection of NG-nitro-<sc>L</sc>-arginine methyl ester (<sc>L</sc>-NAME), a non-selective inhibitor of NO synthase (NOS). NO production was also significantly suppressed in the glioma group, but not the control group, by intraperitoneal injection of 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT), a selective inhibitor of inducible NOS (iNOS). On immunohistochemical examination, diffuse iNOS-positive cells were located within glioma tissue. ED1-positive cells (microglia/macrophages) were intermingled between glioma cells on double immunostaining. These results indicate that the basal level of NO production in the glioma group is higher than that in the control group and that the increased NO production was continuously induced by iNOS-expressing cells in glioma.<br>

収録刊行物

参考文献 (53)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ